Polymorphism in COX-2 modifies the inverse association between <it>Helicobacter pylori </it>seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study

<p>Abstract</p> <p>Background</p> <p>Overexpression of Cyclooxygenase-2 (COX-2) was observed in many types of cancers, including esophageal squamous cell carcinoma (ESCC). One functional SNP, COX-2 -1195G/A, has been reported to mediate susceptibility of ESCC in Chinese...

Full description

Bibliographic Details
Main Authors: Lee Jang-Ming, Lee Ka-Wo, Wu I-Chen, Lee Chien-Hung, Kuo Chao-Hung, Hu Huang-Ming, Goan Yih-Gang, Chou Shah-Hwa, Kao Ein-Long, Wu Ming-Tsang, Wu Deng-Chyang
Format: Article
Language:English
Published: BMC 2009-05-01
Series:BMC Gastroenterology
Online Access:http://www.biomedcentral.com/1471-230X/9/37
_version_ 1818050007104749568
author Lee Jang-Ming
Lee Ka-Wo
Wu I-Chen
Lee Chien-Hung
Kuo Chao-Hung
Hu Huang-Ming
Goan Yih-Gang
Chou Shah-Hwa
Kao Ein-Long
Wu Ming-Tsang
Wu Deng-Chyang
author_facet Lee Jang-Ming
Lee Ka-Wo
Wu I-Chen
Lee Chien-Hung
Kuo Chao-Hung
Hu Huang-Ming
Goan Yih-Gang
Chou Shah-Hwa
Kao Ein-Long
Wu Ming-Tsang
Wu Deng-Chyang
author_sort Lee Jang-Ming
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Overexpression of Cyclooxygenase-2 (COX-2) was observed in many types of cancers, including esophageal squamous cell carcinoma (ESCC). One functional SNP, COX-2 -1195G/A, has been reported to mediate susceptibility of ESCC in Chinese populations. In our previous study, the presence of <it>Helicobacter pylori </it>(<it>H. pylori</it>) was found to play a protective role in development of ESCC. The interaction of COX-2 and <it>H. pylori </it>in gastric cancer was well investigated. However, literature on their interaction in ESCC risk is scarce. The purpose of this study was to evaluate the association and interaction between COX-2 single nucleotide polymorphism (SNP), <it>H. pylori </it>infection and the risk of developing ESCC.</p> <p>Methods</p> <p>One hundred and eighty patients with ESCC and 194 controls were enrolled in this study. Personal data regarding related risk factors, including alcohol consumption, smoking habits and betel quid chewing, were collected via questionnaire. Genotypes of the COX-2 -1195 polymorphism were determined by PCR-based restriction fragment length polymorphism. <it>H. pylori </it>seropositivity was defined by immunochromatographic screening test. Data was analyzed by chi-squared tests and polytomous logistics regression.</p> <p>Results</p> <p>In analysis adjusting for the covariates and confounders, <it>H. pylori </it>seropositivity was found to be inversely association with the ESCC development (adjusted OR: 0.5, 95% CI: 0.3 – 0.9). COX-2 -1195 AA homozygous was associated with an increased risk of contracting ESCC in comparison with the non-AA group, especially among patients with <it>H. pylori </it>seronegative (adjusted OR ratio: 2.9, 95% CI: 1.2 – 7.3). The effect was strengthened among patients with lower third ESCC (adjusted OR ratio: 6.9, 95% CI 2.1 – 22.5). Besides, <it>H. pylori </it>seropositivity conveyed a notably inverse effect among patients with COX-2 AA polymorphism (AOR ratio: 0.3, 95% CI: 0.1 – 0.9), and the effect was observed to be enhanced for the lower third ESCC patients (AOR ratio: 0.09, 95% CI: 0.02 – 0.47, <it>p </it>for multiplicative interaction 0.008)</p> <p>Conclusion</p> <p><it>H. pylori </it>seropositivity is inversely associated with the risk of ESCC in Taiwan, and COX-2 -1195 polymorphism plays a role in modifying the influence between <it>H. pylori </it>and ESCC, especially in lower third esophagus.</p>
first_indexed 2024-12-10T10:46:37Z
format Article
id doaj.art-dea451ecb5be48fe8fb8e3296eb58aa9
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-12-10T10:46:37Z
publishDate 2009-05-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-dea451ecb5be48fe8fb8e3296eb58aa92022-12-22T01:52:09ZengBMCBMC Gastroenterology1471-230X2009-05-01913710.1186/1471-230X-9-37Polymorphism in COX-2 modifies the inverse association between <it>Helicobacter pylori </it>seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control studyLee Jang-MingLee Ka-WoWu I-ChenLee Chien-HungKuo Chao-HungHu Huang-MingGoan Yih-GangChou Shah-HwaKao Ein-LongWu Ming-TsangWu Deng-Chyang<p>Abstract</p> <p>Background</p> <p>Overexpression of Cyclooxygenase-2 (COX-2) was observed in many types of cancers, including esophageal squamous cell carcinoma (ESCC). One functional SNP, COX-2 -1195G/A, has been reported to mediate susceptibility of ESCC in Chinese populations. In our previous study, the presence of <it>Helicobacter pylori </it>(<it>H. pylori</it>) was found to play a protective role in development of ESCC. The interaction of COX-2 and <it>H. pylori </it>in gastric cancer was well investigated. However, literature on their interaction in ESCC risk is scarce. The purpose of this study was to evaluate the association and interaction between COX-2 single nucleotide polymorphism (SNP), <it>H. pylori </it>infection and the risk of developing ESCC.</p> <p>Methods</p> <p>One hundred and eighty patients with ESCC and 194 controls were enrolled in this study. Personal data regarding related risk factors, including alcohol consumption, smoking habits and betel quid chewing, were collected via questionnaire. Genotypes of the COX-2 -1195 polymorphism were determined by PCR-based restriction fragment length polymorphism. <it>H. pylori </it>seropositivity was defined by immunochromatographic screening test. Data was analyzed by chi-squared tests and polytomous logistics regression.</p> <p>Results</p> <p>In analysis adjusting for the covariates and confounders, <it>H. pylori </it>seropositivity was found to be inversely association with the ESCC development (adjusted OR: 0.5, 95% CI: 0.3 – 0.9). COX-2 -1195 AA homozygous was associated with an increased risk of contracting ESCC in comparison with the non-AA group, especially among patients with <it>H. pylori </it>seronegative (adjusted OR ratio: 2.9, 95% CI: 1.2 – 7.3). The effect was strengthened among patients with lower third ESCC (adjusted OR ratio: 6.9, 95% CI 2.1 – 22.5). Besides, <it>H. pylori </it>seropositivity conveyed a notably inverse effect among patients with COX-2 AA polymorphism (AOR ratio: 0.3, 95% CI: 0.1 – 0.9), and the effect was observed to be enhanced for the lower third ESCC patients (AOR ratio: 0.09, 95% CI: 0.02 – 0.47, <it>p </it>for multiplicative interaction 0.008)</p> <p>Conclusion</p> <p><it>H. pylori </it>seropositivity is inversely associated with the risk of ESCC in Taiwan, and COX-2 -1195 polymorphism plays a role in modifying the influence between <it>H. pylori </it>and ESCC, especially in lower third esophagus.</p>http://www.biomedcentral.com/1471-230X/9/37
spellingShingle Lee Jang-Ming
Lee Ka-Wo
Wu I-Chen
Lee Chien-Hung
Kuo Chao-Hung
Hu Huang-Ming
Goan Yih-Gang
Chou Shah-Hwa
Kao Ein-Long
Wu Ming-Tsang
Wu Deng-Chyang
Polymorphism in COX-2 modifies the inverse association between <it>Helicobacter pylori </it>seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
BMC Gastroenterology
title Polymorphism in COX-2 modifies the inverse association between <it>Helicobacter pylori </it>seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
title_full Polymorphism in COX-2 modifies the inverse association between <it>Helicobacter pylori </it>seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
title_fullStr Polymorphism in COX-2 modifies the inverse association between <it>Helicobacter pylori </it>seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
title_full_unstemmed Polymorphism in COX-2 modifies the inverse association between <it>Helicobacter pylori </it>seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
title_short Polymorphism in COX-2 modifies the inverse association between <it>Helicobacter pylori </it>seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
title_sort polymorphism in cox 2 modifies the inverse association between it helicobacter pylori it seropositivity and esophageal squamous cell carcinoma risk in taiwan a case control study
url http://www.biomedcentral.com/1471-230X/9/37
work_keys_str_mv AT leejangming polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT leekawo polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT wuichen polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT leechienhung polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT kuochaohung polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT huhuangming polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT goanyihgang polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT choushahhwa polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT kaoeinlong polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT wumingtsang polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy
AT wudengchyang polymorphismincox2modifiestheinverseassociationbetweenithelicobacterpyloriitseropositivityandesophagealsquamouscellcarcinomariskintaiwanacasecontrolstudy